Edward N. and Della L. Thome Memorial Foundation, Bank of America, N.A., Trustee, Awards Program in Alzheimer's Disease Drug Discovery Research
The Edward N. & Della L. Thome Memorial Foundation was created in 2002 to advance the health of older adults through the support of direct service projects and medical research on diseases and disorders affecting older adults.
The goal of the 2015 Awards Program Program in Alzheimer’s Disease Drug Discovery Research is to support innovative drug discovery research that will lead to improved therapies for individuals suffering from Alzheimer’s disease.
The 2015 Awards Program supports research dedicated to the validation and testing of target compounds and therapeutic agents including biologics and small molecules. Consideration will be given to research based on the amyloid hypothesis as well as alternative pathogenic mechanisms such as APOE, inflammatory and tau-related pathways. Basic research or new target discovery, genetic studies, biomarker research, neuro-imaging and clinical studies are currently outside the scope of this Program.
All applicants must hold a faculty appointment at a non-profit academic, medical, non-governmental or research institution in the United States. US citizenship is not required. Applicants do not need to be nominated by their institutions. Preference will be given to originality of ideas, regardless of faculty seniority.